,MT2

Xiaodan Wang1, Lixia Zhuo2, Wei Wu2

  • 1Department of Anesthesiology and Perioperative Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China; Center for Brain Science, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.

Neuropharmacology
|August 24, 2025
PubMed
まとめ

メラトニンMT2受容体の欠乏は,前帯状皮質 (ACC) を破壊することによって,不安のような行動を引き起こす. ACCにおけるMT2シグナリングの回復は,これらの不安現象を緩和し,治療目標を示唆します.